Search Within

Sherry Shen

Formats
  1. Meeting Abstract (16)
  2. Journal Article (8)
  3. Review (4)
Groups
  1. GME, Medicine (28)
  2. Graduate Medical Education (28)
  3. Hematology-Oncology Fellows (28)
  4. Department of Medicine (26)
  5. Solid Tumor Oncology Division (26)
  6. Breast Medicine Service (22)

More Groups

People
  1. Neil Iyengar (14)
  2. Yuan Chen (13)
  3. Komal Jhaveri (8)
  4. Mark Robson (7)
  5. Cassandra Chang (6)
  6. Pedram Razavi (6)

More People

Years
  1. 2025 (7)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (1)
Publications
  1. Journal of Clinical Oncology (15)
  2. npj Breast Cancer (2)
  3. Cancer (1)
  4. Cancer Treatment Reviews (1)
  5. Current Breast Cancer Reports (1)
  6. Future Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Elsevier B.V. (2)
  3. Nature Publishing Group (2)
  4. C M P Medica LLC * The Oncology Group (1)
  5. Elsevier Inc. (1)
  6. Future Medicine (1)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
    Review

    Rubinstein, M.; Shen, S.; Monk, B. J.; Tan, D. S. P.; Nogueira-Rodrigues, A.; Aoki, D.; Sehouli, J.; Makker, V.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Shen, S.; Salehi, E.; Farooki, A.; Flory, J.; Williams, D.; Carpio, A.; Chang, C.; Lacouture, M. E.; Andreopoulou, E.; Sardesai, S. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of alpelisib-associated hyperglycemia in metastatic breast cancer
    Meeting Abstract

    Shen, S.; Chen, Y.; Carpio, A.; Chang, C.; Iyengar, N. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer
    Meeting Abstract

    Shen, S.; Ma, W.; Zhou, Q.; Iasonos, A.; Zhang, Y.; Ross, D. S.; Makker, V.; Chui, M. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The Optimal Living Program: Integrating exercise into cancer care
    Meeting Abstract

    Rowed, K.; Shen, S.; Corcoran, S.; Clayton, J.; Kelly, B.; Smith, A.; Emerzian, M.; Cruz, C.; Robson, M.; Iyengar, N.
    Medicine and Science in Sports and Exercise (2022)

    Fulltext@MSK | Save
  • Insulin-lowering diets in metastatic cancer
    Review

    Shen, S.; Iyengar, N. M.
    Nutrients (2022)

    Fulltext@MSK | Save
  • Obesity and breast cancer risk: The oncogenic implications of metabolic dysregulation
    Journal Article

    Naaman, S. C.; Shen, S.; Zeytinoglu, M.; Iyengar, N. M.
    Journal of Clinical Endocrinology and Metabolism (2022)

    Fulltext@MSK | Save
  • Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
    Journal Article

    Shen, S.; Rubinstein, M. M.; Park, K. J.; Konner, J. A.; Makker, V.
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save